Trial intelligence / Profile preview

Triptorelin prophylaxis before Implanon insertion for irregular vaginal bleeding

2007-005080-10Phase 4Terminated

Sponsor
University Hospitals of Leicester NHS Trust
Start
Nov 2007
Modality
Small Molecules, Peptides, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial comparing Triptorelin pre-treatment plus etonogestrel implant with Control etonogestrel implant only (2 arms). Primary endpoint: Mean number of bleeding and spotting days. Started Nov 2007; status: terminated.

02

Drugs

triptorelinetonogestrel

Beyond the preview

Go deeper on 2007-005080-10.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-005080-10.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call